 |
PDBsum entry 1me3
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Bioorg Med Chem Lett
11:21-29
(2003)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structures of reversible ketone-Based inhibitors of the cysteine protease cruzain.
|
|
L.Huang,
L.S.Brinen,
J.A.Ellman.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The crystal structures of two hydroxymethyl ketone inhibitors complexed to the
cysteine protease cruzain have been determined at 1.1 and 1.2 A resolution,
respectively. These high resolution crystal structures provide the first
structures of non-covalent inhibitors bound to cruzain. A series of compounds
were prepared and tested based upon the structures providing further insight
into the key binding interactions.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
B.T.Mott,
R.S.Ferreira,
A.Simeonov,
A.Jadhav,
K.K.Ang,
W.Leister,
M.Shen,
J.T.Silveira,
P.S.Doyle,
M.R.Arkin,
J.H.McKerrow,
J.Inglese,
C.P.Austin,
C.J.Thomas,
B.K.Shoichet,
and
D.J.Maloney
(2010).
Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB.
|
| |
J Med Chem,
53,
52-60.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.D.Durrant,
H.Keränen,
B.A.Wilson,
and
J.A.McCammon
(2010).
Computational identification of uncharacterized cruzain binding sites.
|
| |
PLoS Negl Trop Dis,
4,
e676.
|
 |
|
|
|
|
 |
K.Brak,
I.D.Kerr,
K.T.Barrett,
N.Fuchi,
M.Debnath,
K.Ang,
J.C.Engel,
J.H.McKerrow,
P.S.Doyle,
L.S.Brinen,
and
J.A.Ellman
(2010).
Nonpeptidic tetrafluorophenoxymethyl ketone cruzain inhibitors as promising new leads for Chagas disease chemotherapy.
|
| |
J Med Chem,
53,
1763-1773.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.Steert,
M.Berg,
J.C.Mottram,
G.D.Westrop,
G.H.Coombs,
P.Cos,
L.Maes,
J.Joossens,
P.Van der Veken,
A.Haemers,
and
K.Augustyns
(2010).
α-ketoheterocycles as inhibitors of Leishmania mexicana cysteine protease CPB.
|
| |
ChemMedChem,
5,
1734-1748.
|
 |
|
|
|
|
 |
Y.T.Chen,
L.S.Brinen,
I.D.Kerr,
E.Hansell,
P.S.Doyle,
J.H.McKerrow,
and
W.R.Roush
(2010).
In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi.
|
| |
PLoS Negl Trop Dis,
4,
0.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
I.D.Kerr,
J.H.Lee,
C.J.Farady,
R.Marion,
M.Rickert,
M.Sajid,
K.C.Pandey,
C.R.Caffrey,
J.Legac,
E.Hansell,
J.H.McKerrow,
C.S.Craik,
P.J.Rosenthal,
and
L.S.Brinen
(2009).
Vinyl sulfones as antiparasitic agents and a structural basis for drug design.
|
| |
J Biol Chem,
284,
25697-25703.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
I.Redzynia,
A.Ljunggren,
A.Bujacz,
M.Abrahamson,
M.Jaskolski,
and
G.Bujacz
(2009).
Crystal structure of the parasite inhibitor chagasin in complex with papain allows identification of structural requirements for broad reactivity and specificity determinants for target proteases.
|
| |
FEBS J,
276,
793-806.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
F.C.Reis,
T.F.Costa,
T.Sulea,
A.Mezzetti,
J.Scharfstein,
D.Brömme,
R.Ménard,
and
A.P.Lima
(2007).
The propeptide of cruzipain--a potent selective inhibitor of the trypanosomal enzymes cruzipain and brucipain, and of the human enzyme cathepsin F.
|
| |
FEBS J,
274,
1224-1234.
|
 |
|
|
|
|
 |
T.Hogg,
K.Nagarajan,
S.Herzberg,
L.Chen,
X.Shen,
H.Jiang,
M.Wecke,
C.Blohmke,
R.Hilgenfeld,
and
C.L.Schmidt
(2006).
Structural and functional characterization of Falcipain-2, a hemoglobinase from the malarial parasite Plasmodium falciparum.
|
| |
J Biol Chem,
281,
25425-25437.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Kennedy,
A.Nelson,
and
A.Perry
(2005).
Methods for the synthesis of polyhydroxylated piperidines by diastereoselective dihydroxylation: exploitation in the two-directional synthesis of aza-C-linked disaccharide derivatives.
|
| |
Beilstein J Org Chem,
1,
2.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |